Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

NCT00481871 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Lymphoproliferative Malignancies
Hodgkin's Lymphoma
Peripheral T-cell Lymphoma
B-cell Lymphoma
Waldenstrom's Macroglobulinemia

Interventions

DRUG: Pralatrexate Injection
DRUG: Gemcitabine Hydrochloride
DIETARY_SUPPLEMENT: Vitamin B12
DIETARY_SUPPLEMENT: Folic Acid

Sponsor

Acrotech Biopharma Inc.